Korro Bio, Inc.
KRRONASDAQHealthcareBiotechnology
As of Oct 16, 2026 close
- Market cap
- $164.03M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $5.20$55.89
- Volume (live)
- -
- Avg. volume (3M)
- 202.76K
Korro Bio (KRRO) Stock Price & Financial Analysis
Korro Bio Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $8.45 - $9.38 |
|---|---|
| 52-Week High | $55.89 |
| 52-Week Low | $5.20 |
| Open | $9.32 |
| Volume (last close) | 129.23K |
| Average Volume (3M) | 202.76K |
| Revenue (TTM) | 2.38M |
|---|---|
| Net Income (TTM) | -106.64M |
| Free Cash Flow (TTM) | -68.27M |
| EPS (TTM) | −$8.89 |
| Profit Margin | -4477.08% |
| Operating Margin | -3176.57% |
| Return on Equity (ROE) | -103.31% |
| Debt to Equity | 0.41 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 164.03M |
|---|---|
| Shares Outstanding | 17.62M |
| Price to Sales (P/S) | 68.86 |
| Price to Book (P/B) | 1.59 |
| EV/EBITDA | -2.48 |
| 50-Day MA | $11.80 |
|---|---|
| 200-Day MA | $11.76 |
| 1-Year Change | −77.91% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
Korro Bio at a Glance
As of the Oct 16, 2026 close, Korro Bio (KRRO) has a market capitalization of $164.03M. The stock trades at 68.9× sales. Over the trailing twelve months it lost $106.64M on revenue of $2.38M and burned $68.27M of free cash flow. Revenue fell 62.1% year over year.
As of its latest reported balance sheet, it holds $24.91M in cash and securities against $42.21M of debt, a net debt position of $17.31M.
Korro Bio does not currently pay a dividend.
The share price is down 77.9% over the past year. At $8.49 (the Oct 16, 2026 close) it sits near the bottom of its 52-week range of $5.20 to $55.89, below its 200-day moving average of $11.76.
Based on 11 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $19.33, 127.7% above the Oct 16, 2026 close.
Frequently Asked Questions About Korro Bio
What is the current stock price for KRRO?
As of the Oct 16, 2026 close, KRRO stock trades at $8.49. The 52-week range is $5.20–$55.89, with a day range of $8.45–$9.38.
What is the P/E ratio for KRRO?
The P/E ratio (Price-to-Earnings) for KRRO is shown in the Key Statistics section. This valuation metric helps compare Korro Bio, Inc. to industry peers.
Does KRRO pay dividends?
Korro Bio does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for KRRO?
Based on ratings from 11 professional analysts over the last 90 days, the consensus for KRRO is Buy. The average 12-month price target is $19.33, a 127.7% upside from the Oct 16, 2026 close of $8.49.
What is the market cap of KRRO?
As of the Oct 16, 2026 close, Korro Bio's market capitalization is $149.6M, classifying it as a micro-cap company. Korro Bio operates in the Healthcare sector within the Biotechnology industry.